The UK-based organisation Findacure invited EspeRare to present its innovative model at a conference on drug repositioning. This annual event brings together in London major stakeholders in the field (patient groups, clinicians, researchers and life sciences professionals) on the occasion of World Rare Disease Day. This is a unique opportunity for all these actors to discuss the latest advances in drug repositioning as a source of future treatments for rare diseases.
Caroline Kant, EspeRare's CEO, will explain the philanthropic venture model and how it accelerates the development of treatments for rare diseases. Click here for details on her presentation.
Picture credit: Barbara Asboth
